Current and future treatments for cognitive deficits in dementia

Area of Science:

• Neurology
• Pharmacology
• Molecular Biology

Background:

• Alzheimer's disease (AD) is characterized by amyloid plaques and neurofibrillary tangles.
• Understanding the molecular biology of these hallmarks is crucial for developing effective treatments.
• Emerging research highlights the roles of inflammation, oxidative stress, vascular factors, and neurochemical changes in AD pathogenesis.

Purpose of the Study:

• To provide an overview of current and investigational therapeutic strategies for Alzheimer's disease (AD).
• To discuss treatments targeting the primary pathological hallmarks of AD.
• To explore therapies addressing secondary mechanisms implicated in AD progression.

Main Methods:

• Review of marketed and late-stage development treatments for Alzheimer's disease.
• Analysis of research into the molecular biology of amyloid plaques and neurofibrillary tangles.
• Discussion of therapeutic targets related to inflammation, oxidative stress, vascular, and neurochemical alterations in AD.

Main Results:

• Significant progress has been made in understanding the molecular basis of AD pathology.
• Multiple therapeutic avenues are being pursued, targeting both core hallmarks and associated mechanisms.
• A range of treatments are currently marketed or in advanced development stages.

Conclusions:

• Current and future Alzheimer's disease (AD) treatments are multifaceted, addressing key pathologies and contributing factors.
• Continued research into molecular mechanisms is vital for advancing AD therapeutics.
• A combination of approaches may be necessary for effective AD management.